XRTX
XORTX Therapeutics IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$3.77M
P/E Ratio
—
EPS
$-2.45
Beta
0.22
52W High
$7.05
52W Low
$1.73
50-Day MA
$2.37
200-Day MA
$3.02
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
0.96
PEG Ratio
—
About XORTX Therapeutics Inc
XORTX Therapeutics Inc., a biopharmaceutical company, is dedicated to the development and commercialization of therapies to treat progressive kidney disease, hypertension, insulin resistance, and diabetic nephropathy. The company is headquartered in Vancouver, Canada.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-2.40M |
| Operating Margin | 0.00% |
| Return on Equity | -137.40% |
| Return on Assets | -53.80% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.30 |
| Price-to-Book | 2.94 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | 0.09 |
| Quarterly Earnings Growth (YoY) | -97.20% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $1.73M |
| Float | $1.37M |
| % Insiders | 9.24% |
| % Institutions | 2.50% |
Historical Volatility
HV 10-Day
183.14%
HV 20-Day
137.90%
HV 30-Day
140.11%
HV 60-Day
135.08%
HV Rank
79.4%
Volatility is currently expanding
More HEALTHCARE Stocks
Data last updated: 5/25/2026